Product Information
PRAZOSIN 1 MG CAPSULE is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.0842 per EA under NDC 00378110110. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on May 16, 1989. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378110110
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PRAZOSIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA072575FDA Approved
5/16/1989
TE Code
AB
On Market Since
2/28/1989
Pharmacological Classes
Price Statistics
The NADAC for PRAZOSIN 1 MG CAPSULE has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 36.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0842 per EA |
|---|---|
| All-time high | $0.4370 (Apr 13, 2016) |
| All-time low | $0.0834 (Apr 22, 2026) |
| 52-week high | $0.1052 |
| 52-week low | $0.0834 |
| Median price | $0.2398 |
| Average price | $0.2511 |
| Largest weekly change | +51.3% (Aug 21, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
prazosin hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PRAZOSIN 1 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PRAZOSIN 1 MG CAPSULE, manufactured by Mylan Pharmaceuticals Inc., is $0.0842 per EA (NDC 00378110110), effective Sep 30, 2026.
How has the price of PRAZOSIN 1 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PRAZOSIN 1 MG CAPSULE has declined 36.0%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for PRAZOSIN 1 MG CAPSULE?
Since Nov 28, 2013, the NADAC for PRAZOSIN 1 MG CAPSULE has ranged from a low of $0.0834 (Apr 22, 2026) to a high of $0.4370 (Apr 13, 2016), with a median of $0.2398 per EA.
Are there cheaper alternatives to PRAZOSIN 1 MG CAPSULE?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PRAZOSIN 1 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures PRAZOSIN 1 MG CAPSULE?
PRAZOSIN 1 MG CAPSULE (NDC 00378110110) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.